首页> 外国专利> INDUCED MALIGNANT STEM CELLS OR PRE INDUCTION CANCER STEM CELLS CAPABLE OF SELF REPLICATION OUTSIDE OF AN ORGANISM PRODUCTION METHOD FOR SAME AND PRACTICAL APPLICATION FOR SAME

INDUCED MALIGNANT STEM CELLS OR PRE INDUCTION CANCER STEM CELLS CAPABLE OF SELF REPLICATION OUTSIDE OF AN ORGANISM PRODUCTION METHOD FOR SAME AND PRACTICAL APPLICATION FOR SAME

机译:能够同时在有机生产方法之外进行自我复制的诱导恶性干细胞或预诱导癌干细胞

摘要

Disclosed are inducible cancer stem cells which are capable of in vitro self replication and which are useful in research into cancer treatment and cancer related drug development. Also disclosed are a production method for the above cells cancer cells induced from the above stem cells and a practical application of the cells. The disclosed inducible cancer stem cells which are capable of in vitro self replication are characterised by satisfying requirements (1) and (2): (1) expressing six genes (POU5F1 gene NANOG gene SOX2 gene ZFP42 gene LIN28 gene and TERT gene) selected from among a specified gene group; (2) (a) having an abnormality which is either the modification of an endogenous cancer suppression gene or the up regulation of an endogenous cancer related gene.
机译:公开了可诱导的癌症干细胞,其能够在体外自我复制,并且可用于癌症治疗和癌症相关药物开发的研究。还公开了由上述干细胞诱导的上述细胞癌细胞的生产方法和该细胞的实际应用。公开的能够体外自我复制的可诱导癌干细胞的特征在于满足要求(1)和(2):(1)表达选自以下的六个基因(POU5F1基因NANOG基因SOX2基因ZFP42基因LIN28基因和TERT基因)。在指定的基因组中; (2)(a)具有内源性癌症抑制基因的修饰或内源性癌症相关基因的上调的异常。

著录项

  • 公开/公告号IN2012DN11136A

    专利类型

  • 公开/公告日2014-10-24

    原文格式PDF

  • 申请/专利权人

    申请/专利号IN11136/DELNP/2012

  • 发明设计人 ISHIKAWA TETSUYA;

    申请日2012-12-21

  • 分类号C12N15/11;G01N33/50;C12N15/09;G01N33/15;A61K35/12;C12Q1/68;C12Q1/02;A61P35;C12N5/95;C12N15/85;C12N5/09;A01K67/27;C12N5/10;A61K39;

  • 国家 IN

  • 入库时间 2022-08-21 15:57:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号